Pacific Life Insurance Fit Review for Type 1 Diabetes

Research Snapshot

Why Pacific Life Qualified for This Study

Questions This Section Answers

• Is Pacific Life a good choice for life insurance for Type 1 diabetes?
• Why did AI platforms include Pacific Life in the Type 1 diabetes carrier ranking?

Pacific Life qualified because four of seven platforms named it during ranking discovery, and every platform that evaluated it treated it as a legitimate carrier to quote rather than a disqualifying profile ^[6]. Its inclusion rests on product breadth and underwriting structure, not on documented Type 1 diabetes outcomes.

The company sells individual term and permanent life insurance, including PL Promise Term, indexed universal life, and whole life ^[9]. Its application materials specifically ask about diabetes and related medical conditions, so the condition is reviewed rather than auto-declined ^[11].

Independent sources describe Pacific Life as historically more competitive for well-controlled diabetics ^[7], and one 2026 independent ranking placed it first overall for diabetics ^[15]. Those are third-party characterizations, not company-published criteria.

Financial strength is the least disputed point: A+ (Superior) from AM Best, AA- from S&P and Fitch, Aa3 from Moody's, and $1.5 trillion of life insurance in force ^[16]. That matters for multi-decade term and permanent guarantees.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 1 Diabetes

Questions This Section Answers

• Which Pacific Life plan should a buyer with Type 1 diabetes choose for term coverage?
• Does PL Promise Term offer level premiums and a conversion option for a Type 1 diabetic buyer?

PL Promise Term is the most directly relevant Pacific Life product for this use case. It provides level premiums for 10, 15, 20, 25, or 30 years with a $50,000 minimum death benefit, and it permits conversion of all or part of the coverage during the level-premium period while the insured is age 70 or younger, subject to policy terms ^[20].

Published materials list up to $3 million for PL Promise Term through accelerated or modified underwriting, while traditional underwriting remains available for all face amounts ^[24]. One platform reported a conflicting accelerated-underwriting cap of $2 million versus $3 million across independent reviews, so the exact cap should be verified for the specific product and case ^[26].

Permanent alternatives include PL Promise GUL, which materials describe as offering guaranteed death-benefit protection with level premiums, alongside disclosed surrender charges during specified early policy years ^[27]. One independent review describes PL Promise GUL face amounts as low as $25,000 ^[29]. Pacific Life also markets indexed universal life and variable universal life ^[30].

Platforms named slightly different product sets — Pacific Horizon IUL 2 and Pacific Elite Term appeared in one response (anthropic), while others listed only PL Promise Term plus generic permanent options (openai, perplexity, grok, kimi). Buyers should confirm which specific series is available in their state.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Pacific Life for Type 1 diabetes life insurance?
• Is Pacific Life financially strong enough for a long-term Type 1 diabetes policy?

Agreement was strong on structure and financial strength, and unanimous on the absence of published Type 1 diabetes criteria.

All seven platforms that evaluated Pacific Life agreed the company does not publicly disclose Type 1 diabetes-specific underwriting guidelines, A1C thresholds, or approval criteria ^[32]. This is the single most consistent finding in the study.

Platforms also agreed on the core product facts: PL Promise Term offers 10-, 15-, 20-, 25-, or 30-year level premiums, a $50,000 minimum death benefit, and conversion rights ^[39]. Multiple platforms described the PAL+ underwriting structure with accelerated, modified, and traditional pathways ^[32].

Financial strength drew consistent agreement: A+ from AM Best and comparable ratings from S&P, Fitch, and Moody's ^[47].

Platforms also agreed that Pacific Life sells through licensed agents and brokers rather than direct online purchase, with no instant-quote path for complex health profiles ^[51].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• How favorable is Pacific Life's underwriting for Type 1 diabetes compared with other carriers?
• Can a Type 1 diabetic qualify for Pacific Life accelerated underwriting without a medical exam?

Fit ratings diverged: openai, anthropic, google, and perplexity rated Pacific Life a good fit; grok and deepseek rated it mixed; kimi rated it uncertain. That split reflects evidence gaps rather than a factual dispute about the company.

The sharpest conflict concerns accelerated underwriting. One platform reported that Pacific Life may offer Type 1 diabetics coverage without a medical exam ^[54], while another reported that diabetes is listed among conditions that can preclude accelerated underwriting and that Type 1 diabetics must go through traditional underwriting with exams, labs, and an attending physician statement ^[56]. Pacific Life's own materials describe accelerated underwriting as available to qualifying applicants, not as guaranteed ^[59].

A1C thresholds are also unresolved. One independent source reported that Pacific Life accepts well-controlled diabetics with A1C up to 7.5% ^[60], but this is not confirmed in Pacific Life's official materials and may vary by product or underwriter discretion. Another platform reported that underwriters generally define reasonable control as A1C between 7.0 and 8.0, with Standard Non-Tobacco as the typical best case ^[61].

Rate-class expectations conflict as well. One platform reported that Type 1 applicants rarely qualify for preferred rates at traditional carriers including Pacific Life and typically receive standard or rated classes ^[62]. Another reported that exceptional, early-diagnosed applicants using continuous glucose monitors and insulin pumps might occasionally negotiate Standard Plus, though this is rare and undocumented in official underwriting literature ^[61].

One platform found no independent source that evaluated Pacific Life specifically for diabetes life insurance at all, and noted that competitors have explicitly documented diabetes programs while Pacific Life does not ^[64].

A 2026 class-action settlement adds a separate uncertainty: Pacific Life agreed to a $58.3 million settlement over allegations of misleading illustrations on indexed universal life products, specifically Pacific Discovery Xelerator IUL, with the company denying wrongdoing ^[66]. The settlement did not specify whether term products were affected.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What underwriting pathways does Pacific Life offer a Type 1 diabetic applicant?
• How much coverage can a Type 1 diabetic buyer get from Pacific Life without a medical exam?

Pacific Life's most relevant capability for this use case is a three-pathway underwriting structure that routes applications to the least invasive option available. PAL+ includes accelerated underwriting for qualifying applicants, modified underwriting requiring a recent physical and laboratory work, and traditional underwriting when the other pathways are unavailable ^[70].

Coverage capacity is substantial on paper. Published PAL+ materials list up to $3 million for PL Promise Term through accelerated or modified pathways, with traditional underwriting available for all face amounts ^[70]. One independent review reported accelerated underwriting available for ages 18 to 80, with no-exam approval up to $3 million for eligible cases ^[74]. The practical amount available to a person with Type 1 diabetes remains dependent on underwriting and financial justification.

Conversion is the second key capability. PL Promise Term permits conversion of all or part of the coverage during the level-premium period while the insured is age 70 or younger, subject to policy terms ^[75]. One independent review described conversion rights during the first 10 years or until age 65 without new medical underwriting, a narrower window than the company materials describe ^[77]. Buyers should confirm the exact deadline in the issued policy.

For applicants who do not qualify for standard rates, one platform reported that Pacific Life offers table-rated (flat extra premium) and exclusion rider options, with all classes available with flat extra premium or exclusion rider in most cases ^[78]. Another reported that PL Promise Term caps substandard ratings at Table H (300% of standard) for ages 18–75 and Table D (200%) for ages 76–80, with declines beyond those caps ^[80].

Pacific Life states it is licensed to issue insurance in all states except New York, and product availability and features vary by state ^[81].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Pacific Life cost per month for a Type 1 diabetic, and are there setup or cancellation fees?
• What fees and surrender charges apply to Pacific Life permanent policies for a Type 1 diabetic buyer?

No public, applicant-specific premium quote for Type 1 diabetes was identified by any platform. Pricing confidence was low across openai, deepseek, grok, perplexity, and kimi, and moderate for anthropic and google.

General pricing benchmarks exist but are not diabetes-specific. One independent review reported Pacific Life term rates running 4% to 20% below national average, with a company-wide average annual premium of $280 versus an industry average of $382 ^[83]. Another reported sample rates for a 35-year-old female on a 10-year term starting at $47.43 per month ^[83]. These figures do not reflect table ratings that Type 1 diabetes may trigger.

For context on what Type 1 diabetes pricing can look like, one independent source reported industry average rates for 40-year-old nonsmokers with well-controlled Type 1 diabetes at $52 (women) and $66 (men) for $500,000 of 20-year term coverage ^[85]. Pacific Life's position relative to those benchmarks is unknown.

Known cost structure: PL Promise Term requires ongoing premiums during the selected level-premium period, with the amount individualized ^[86]. The published materials identify a $50,000 minimum face amount but do not publish a universal premium schedule ^[87]. Optional riders may increase cost, and the reviewed public materials do not provide a complete applicant-specific rider-fee schedule ^[88].

Permanent policies carry additional complexity. PL Promise GUL materials describe surrender charges for full surrender and certain face-amount reductions or withdrawals during early policy years ^[89]. Permanent products may also involve cash-value, lapse, surrender, and policy-loan considerations ^[86]. One platform reported that a Table 4 substandard rating typically adds a 100% surcharge to the base standard premium, and that table ratings of Table 2–4 multiply the base standard premium by roughly 1.25x to 2x ^[90].

Contract terms: PL Promise Term has a selected level-premium period and a conversion feature, with conversion eligibility and available products to be confirmed in the policy ^[86]. After the level-premium period expires, rates increase unless the policy is converted ^[91]. Product forms, availability, underwriting rules, and features vary by state ^[92].

Best Suited For

Questions This Section Answers

• Who is Pacific Life best suited for among Type 1 diabetes life insurance buyers?
• Is Pacific Life a good fit for a Type 1 diabetic who wants term coverage with a future conversion option?

Pacific Life is best suited for Type 1 diabetics with stable control, no major complications, and a willingness to complete full medical underwriting.

Platforms most consistently described these buyer profiles as good fits: applicants seeking conventional term coverage with 10- to 30-year level premiums (openai, anthropic, perplexity); applicants who may benefit from accelerated, modified, or traditional underwriting pathways (openai, anthropic, google); applicants who want a term policy with a future conversion option (openai, anthropic, google); and applicants needing permanent death-benefit protection who can tolerate higher and more complex premiums than term insurance (openai, anthropic, deepseek).

One platform specifically described higher face amounts for affluent applicants with stable Type 1 diabetes as a strong use case, noting Pacific Life is competitive for large face amounts of $1,000,000 and above ^[93].

Another described adults with highly stable, well-controlled Type 1 diabetes and an A1C consistently between 7.0 and 8.0 as the core fit, provided kidney function is normal ^[95].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Pacific Life for life insurance with Type 1 diabetes?
• Is Pacific Life a poor fit for a Type 1 diabetic who wants guaranteed approval or no medical exam?

Pacific Life is probably not the best fit for Type 1 diabetics who need guaranteed approval, who want to avoid medical underwriting entirely, or whose diabetes is poorly controlled or complicated.

Platforms consistently flagged these exclusions: applicants seeking guaranteed-issue or simplified-issue coverage specifically designed to avoid detailed medical underwriting (openai, anthropic, deepseek, perplexity); applicants whose diabetes has significant complications or unstable control and who need a carrier with a demonstrably more favorable diabetes underwriting history (openai, anthropic, google); applicants who need a firm premium quote before completing health and financial underwriting (openai); and applicants comparing only the lowest possible term premium without obtaining competing offers (openai).

One platform added that buyers specifically wanting traditional participating whole life insurance are not a fit, because Pacific Life does not offer dividend-paying whole life (anthropic). Another noted that buyers who exclusively want to purchase direct online without working through a licensed financial professional are not a fit ^[96].

For Type 1 diabetics with poorly controlled blood sugar, high A1C levels above 8%, or serious complications such as nephropathy, neuropathy, or advanced retinopathy, multiple platforms recommended evaluating other carriers (anthropic, google, perplexity).

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Pacific Life for a Type 1 diabetic who needs a diabetes-specific underwriting program?
• When should a Type 1 diabetic buyer choose Banner Life or John Hancock over Pacific Life?

Another carrier may be better in several specific situations that platforms identified.

If the applicant needs a diabetes-specific program with documented criteria, John Hancock's Aspire program is the only provider one platform identified as designed specifically for diabetes, with Vitality PLUS wellness integration and up to 25% premium savings ^[99]. Aspire is not available in Idaho and New York ^[101].

If the applicant needs explicit Type 1 diabetes approval thresholds, one platform reported that Banner Life approves Type 1 patients using fewer than 50 insulin units daily ^[101]. Another platform named Banner Life and American General (Corebridge) as potentially offering more flexible table-rated pricing or approval rates for poor glucose control (anthropic).

If the applicant needs guaranteed-issue or simplified-issue coverage, specialized guaranteed-issue carriers are more appropriate (openai, anthropic, deepseek, perplexity).

If the applicant wants traditional whole life with dividend potential, mutual companies such as MassMutual, New York Life, or Penn Mutual were named as better choices (anthropic).

If the applicant is over age 70 and needs permanent coverage without expiration, lifetime conversion rights and simplified-issue policies from other carriers may work better (anthropic).

If the applicant wants the absolute lowest premium at smaller face amounts of $250,000 or less, one platform reported Banner Life is often cited as more competitive at lower coverage levels (anthropic).

If the applicant is in New York, Pacific Life is not an option at all through the cited consumer resource ^[103].

Questions to Verify Before Buying

Questions This Section Answers

• What should a Type 1 diabetic buyer confirm with Pacific Life before signing a contract?
• How can a Type 1 diabetic buyer verify Pacific Life's underwriting class and premium before committing?

These questions come directly from the platform research and should be answered in writing before any application is submitted.

Will Pacific Life consider the applicant for PL Promise Term, and what underwriting class is realistically expected based on the applicant's Type 1 diabetes history (openai)?

How will age at diagnosis, recent and historical A1C values, glucose variability, insulin use, continuous-glucose-monitor data, hypoglycemia, diabetic ketoacidosis, retinopathy, neuropathy, cardiovascular disease, kidney function, blood pressure, and endocrinology follow-up affect underwriting ^[106]?

Will the application qualify for accelerated underwriting, or will an exam, labs, attending-physician statement, or full medical records be required ^[107]?

What are the exact premiums by face amount and term length, including the offered underwriting class and any rider charges (openai, anthropic)?

What happens to premiums after the level-premium period, and what are the conversion deadlines, eligible products, conversion pricing rules, and underwriting requirements ^[109]?

Is the selected product and each desired rider available in the applicant's state ^[110]?

For permanent coverage, what are guaranteed premiums, guaranteed values, non-guaranteed assumptions, surrender charges, lapse risks, and policy-loan effects ^[112]?

How does the Pacific Life offer compare with at least two other carriers that regularly underwrite applicants with Type 1 diabetes ^[113]?

Final AI Consensus Verdict

Pacific Life is a good, not proven best, fit for an otherwise stable adult with Type 1 diabetes. Four of seven platforms named it during ranking discovery, and its average listed rank was 5.0 with a best rank of 3. PL Promise Term is the strongest starting point because of its fixed-premium term options, conversion feature, and multiple underwriting pathways ^[114].

The absence of public Type 1 diabetes-specific underwriting rules and public pricing makes a multi-carrier broker comparison essential ^[116]. Platforms disagreed on whether accelerated underwriting is realistically available to Type 1 diabetics, on A1C thresholds, and on whether standard or table-rated classes are the realistic outcome. Buyers should treat Pacific Life as a carrier worth quoting rather than a confirmed diabetes specialist, and should obtain written underwriting criteria and competing offers before committing.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms — openai, anthropic, google, grok, kimi, deepseek, and perplexity — each evaluating Pacific Life for the query: which life insurance carriers are generally worth considering for applicants with Type 1 diabetes, and why. Four of the seven platforms named Pacific Life during ranking discovery.

The study date is 2026-09-22. Platform-reported research dates differ: deepseek reported 2026-06-11, while the other six platforms reported 2026-09-23. Platform-reported dates are provenance metadata and do not independently prove freshness.

All included platforms evaluated fit, but the platform-mention count reflects only platforms that named the entity during ranking discovery. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. No-search model claims require explicit verification before being described as current facts.

Methodology Limitations

Several limitations affect this review.

Pacific Life's public product materials describe underwriting pathways and product features but do not publish Type 1 diabetes-specific underwriting outcomes ^[119]. No public Pacific Life Type 1 diabetes underwriting guide or guaranteed eligibility criteria was identified by any platform.

No public applicant-specific premiums were identified. Pricing confidence was low across five of seven platforms.

Accelerated underwriting is not guaranteed; medical records, examination, and laboratory testing may still be required ^[119].

Pacific Life materials refer to different product availability, underwriting limits, and state-specific forms; the applicable version must be confirmed for the buyer's state ^[124].

The cited PL Promise materials are primarily intended for financial professionals; consumer-facing disclosures and the issued policy control ^[126].

Platforms disagreed on whether accelerated underwriting is available to Type 1 diabetics, on A1C thresholds, and on realistic rate classes. These conflicts are unresolved in the supplied evidence.

One platform (deepseek) ran with search disabled, so its findings rest on model knowledge rather than retrieved sources.

The 2026 settlement over indexed universal life illustrations did not specify whether term products were affected, and it is unclear whether underwriting or sales practices for diabetics were part of the allegation ^[127].

See the broader Life Insurance for Type 1 Diabetes consensus index for comparisons across qualified options.